FindTrial
Sign In

A randomised double-blind placebo-controlled trial to investigate the efficacy and side-effects of pregabalin for the treatment of neuropathic pain in humans following severe burn injury

A randomised double-blind placebo-controlled trial to investigate the efficacy and side-effects of pregabalin for the treatment of neuropathic pain in humans following severe burn injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN56448626
Enrollment
Unknown
Registered
2004-12-09
Start date
2005-01-01
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic pain following burn injury may occur in the acute or chronic state. Signs and Symptoms Neuropathic pain

Interventions

Randomised trial of pregabalin versus placebo

Sponsors

Royal Brisbane and Women's Hospital (Australia)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have severe burn injuries with elements of neuropathic pain.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

Australia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026